CRSP - Crispr Therapeutics AG - Stock Forecast

Healthcare - Sector
Coverage Performance Price Targets & Ratings Chart Insider Trading

CRSP is currently covered by 21 analysts with an average price target of $74.94. This is a potential upside of $19.29 (34.66%) from yesterday's end of day stock price of $55.65.

Crispr Therapeutics AG's activity chart (see below) currently has 150 price targets and 175 ratings on display. The stock rating distribution of CRSP is 29.63% HOLD, 61.73% BUY and 8.64% SELL.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 65.47% with an average time for these price targets to be met of 99.04 days.

Highest price target for CRSP is $160, Lowest price target is $30, average price target is $74.94.

Most recent stock forecast was given by YIGAL NOCHOMOVITZ from CITI on 18-Apr-2024. First documented stock forecast 15-Nov-2016.

Currently out of the existing stock ratings of CRSP, 24 are a HOLD (29.63%), 50 are a BUY (61.73%), 7 are a SELL (8.64%).

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

89

$33.35 (59.93%)

70

7 days ago

11/16 (68.75%)

$32.84 (58.48%)

196

Buy

90

$34.35 (61.73%)

90

14 days ago

8/11 (72.73%)

$27.09 (43.06%)

214

Sell

48

$-7.65 (-13.75%)

42

1 months 30 days ago

3/6 (50%)

$-38.06 (-44.22%)

144

Hold

80

$24.35 (43.76%)

61

2 months 3 days ago

9/12 (75%)

$-6.19 (-7.18%)

109

Hold

66

$10.35 (18.60%)

57

2 months 3 days ago

6/8 (75%)

$-20.19 (-23.42%)

217

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is CRSP (Crispr Therapeutics AG) average time for price targets to be met?

On average it took 99.04 days on average for the stock forecasts to be realized with a an average price target met ratio 65.47

Which analyst has the current highest performing score on CRSP (Crispr Therapeutics AG) with a proven track record?

JAMES LEE

Which analyst has the most public recommendations on CRSP (Crispr Therapeutics AG)?

James Lee works at MIZUHO and has 38 price targets and 24 ratings on CRSP

Which analyst is the currently most bullish on CRSP (Crispr Therapeutics AG)?

Salveen Richter with highest potential upside - $133.35

Which analyst is the currently most reserved on CRSP (Crispr Therapeutics AG)?

Tyler Van Buren with lowest potential downside - -$25.65

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?